Middletown, United States
U-Pump, founded in 2023 and headquartered in the United States, operates in the Health Care industry with a mission to revolutionize insulin therapy for over 100 million people worldwide in need of better diabetes care.
With its slogan, "AI-powered insulin patch pump: reusable, affordable, for 100M+ people needing better diabetes care," U-Pump stands out for its innovative approach. The company has developed a functional prototype of an AI-powered, reusable insulin patch pump, complete with Continuous Glucose Monitoring (CGM) integration and AI dosing — both validated in simulations.
Regulatory progress includes an FDA Q-Submission (Q250943) and pending ISO tests, reflecting its commitment to high standards. On the commercial side, U-Pump boasts 435 pre-orders, including 131 paid, across regions like the US, EU, MENA, and Israel. With two provisional patents and multiple technical know-how packages secured, the intellectual property framework is robust.
The company is currently raising $200K SAFE (with a $15M cap) to complete ISO certification and pilot studies, aiming for a larger $4.5M Seed Round within nine months to pursue full regulatory clearance and market entry.
